A new perspective argues that a rich class of probability models known as Markov modulated models could transform how ...

In the high-tech, high-competition AI field, we are seeing new versions of models rolled out by the frontier companies (OpenAI, Google and Anthropic) every month and a half. I included a Release ...

Exponent demonstrates strong demand recovery, with Q2 revenue before reimbursement up 12% to $148.9M and EBITDA margin rising to 28.7%. I see sustainable growth potential, but hiring discipline and ...

“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...

But a new study shows that work use cases make up less of the picture than AI companies claim. AI companies like Anthropic and OpenAI regularly publish reports on how people are using products like ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...

Ask a roomful of senior executives what AI can do for their business, and the answers will probably cluster around the same themes: lower costs, smaller headcount, faster processes, leaner operations.

Gen Z might be using the abbreviation for “point of view” incorrectly. But linguists think it’s exciting. By Nitsuh Abebe Two months ago, Griffin Bassett uploaded one of the language-education videos ...